IFNA1 and systemic lupus erythematosus: Together these studies highlight that type I lFN are associated with active lupus manifestations and suggest a potential use of the IFN signature to stratify patients into those with higher and lower risk of developing future severe disease activity and manifestations, and possible predict treatment responses.